Superworth

Guardian Pharmacy Services price to sales ratio GRDN

Market value divided by revenue over the last twelve months, since 2025.

Today, Oct 23, 2026
1.7×
Peer median
2.8×

Guardian Pharmacy Services' price to sales ratio is 1.7× as of Oct 23, 2026.

The median for 10 healthcare stocks of a similar size is 2.8×.

Price to sales ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far1.7×1.2×1.9×
20251.4×1.1×1.4×

Against its peers

Companies in Healthcare nearest Guardian Pharmacy Services' size, closest first, today.

CompanyPrice to sales ratio
GRDNGuardian Pharmacy Services1.7×
TMDXTransMedics3.7×
ADMAAdma Biologics4.7×
MDPediatrix Medical1.2×
UFPTUFP Technologies3.6×
ADUSAddus HomeCare1.5×
PBHPrestige Consumer Healthcare2.0×
NRIXNurix Therapeutics3.9×
PGNYProgyny1.7×
PRVAPrivia Health1.2×
VCELVericel7.1×
Peer median2.8×

What the price to sales ratio tells you

Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.

Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.

More on Guardian Pharmacy Services

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.